Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
News release
by
Poolbeg Pharma PLC
London, UK
|
March 09, 2023 07:53 AM Eastern Standard Time
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
